Grufity logoGrufity logo
StocksFundsSearch Filings

Stericycle Inc Stock Research

SRCL

43.35USD-0.29(-0.66%)Market Closed

Market Summary

USD43.35-0.29
Market Closed
-0.66%

SRCL Alerts

SRCL Stock Price

SRCL RSI Chart

SRCL Valuation

Market Cap

4.0B

Price/Earnings (Trailing)

48.91

Price/Sales (Trailing)

1.47

EV/EBITDA

18.41

Price/Free Cashflow

25.45

SRCL Price/Sales (Trailing)

SRCL Profitability

EBT Margin

2.92%

Return on Equity

2.33%

Return on Assets

1.06%

Free Cashflow Yield

3.93%

SRCL Fundamentals

SRCL Revenue

Revenue (TTM)

2.7B

Revenue Y/Y

3.03%

Revenue Q/Q

2.09%

SRCL Earnings

Earnings (TTM)

81.9M

Earnings Y/Y

180.14%

Earnings Q/Q

-64.8%

Price Action

52 Week Range

39.6356.12
(Low)(High)

Last 7 days

-0.8%

Last 30 days

2.6%

Last 90 days

-11.3%

Trailing 12 Months

-10.5%

SRCL Financial Health

Current Ratio

0.9

Debt/Equity

0.61

Debt/Cashflow

0.13

SRCL Investor Care

Shares Dilution (1Y)

0.43%

Diluted EPS (TTM)

0.88

Peers (Alternatives to Stericycle)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
66.2B
19.9B
-1.84% 3.19%
29.3
3.32
7.84% 18.34%
47.0B
8.6B
0.95% 25.29%
36.26
5.46
13.01% 7.22%
45.1B
14.1B
2.43% 7.15%
29.7
3.2
21.02% 12.77%
41.2B
3.7B
10.07% 59.89%
38.09
11.22
16.24% -0.79%
35.3B
7.5B
-3.49% 8.77%
41.39
4.73
16.63% 33.72%
MID-CAP
7.8B
5.3B
0.23% 62.03%
17.82
1.47
27.32% 93.47%
7.3B
3.8B
-1.59% 9.53%
23.54
1.91
12.95% 25.10%
4.8B
1.1B
5.43% 33.09%
91.88
4.33
19.27% 27.96%
4.0B
2.7B
2.58% -10.51%
48.91
1.47
3.09% 222.06%
SMALL-CAP
800.3M
763.4M
-5.53% 29.23%
9.44
1.05
38.98% 39.07%
148.8M
74.8M
35.08% 95.60%
-51.58
1.99
15.11% -592.15%
10.7M
85.2M
-8.70% -14.86%
-152.36
0.14
22.52% -12062.50%
7.3M
318.1M
-58.03% -48.46%
-0.22
0.02
19.84% 22.30%

Financials for Stericycle

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q12022Q42022Q32022Q22022Q1
Revenue0.7%2,7252,7052,6922,6502,643
Gross Profit1.6%1,0421,0261,0189921,000
  S&GA Expenses-2.5%865888928992983
EBITDA25.1%260208106122-
EBITDA Margin24.5%0.10*0.08*0.04*0.05*-
Earnings Before Taxes39.3%11079.0032.00-70.00-50.50
EBT Margin145.4%0.03*0.01*-0.03*-0.02*-
Interest Expenses6.6%77.0073.0066.0066.0065.00
Net Income45.0%82.0057.008.00-85.90-67.10
Net Income Margin602.9%0.02*0.00*-0.03*-0.03*-
Free Cahsflow885.5%68.007.008.0072.00-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q12022Q42022Q32022Q22022Q1
Assets0.0%5,3325,3345,3415,4085,477
  Current Assets0.9%564559598597614
    Cash Equivalents7.1%60.0056.0044.0046.0060.00
  Net PPE-0.4%713716712720713
  Goodwill0.1%2,7882,7852,74924.002,809
Liabilities-0.8%2,8862,9103,0153,0543,096
  Current Liabilities-6.7%581622587619670
  Long Term Debt0.2%1,4871,4841,6521,6761,678
Shareholder's Equity1.0%2,4452,4202,3222,3542,381
  Retained Earnings0.8%1,4221,4111,3791,3511,341
  Additional Paid-In Capital0.3%1,2891,2851,2811,2711,263
Accumulated Depreciation2.9%677658664681678
Shares Outstanding0.2%92.0092.0092.0092.0092.00
Minority Interest-86.0%1.004.003.004.004.00
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q12022Q42022Q32022Q22022Q1
Cashflow From Operations44.1%289200144135202
  Share Based Compensation8.4%27.0025.0028.0028.0027.00
Cashflow From Investing2.7%-82.30-84.60-120-99.30-102
Cashflow From Financing-82.0%-202-111-8.00-46.30-88.40

Risks for SRCL

What is the probability of a big loss on SRCL?

86.9%


Probability that Stericycle stock will be more than 20% underwater in next one year

60.8%


Probability that Stericycle stock will be more than 30% underwater in next one year.

22.7%


Probability that Stericycle stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does SRCL drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Stericycle was unfortunately bought at previous high price.

Drawdowns

Returns for SRCL

Cumulative Returns on SRCL

-9.0%


10-Year Cumulative Returns

-10.9%


7-Year Cumulative Returns

-7.3%


5-Year Cumulative Returns

-5.3%


3-Year Cumulative Returns

What are the long-term rolling returns for SRCL?

FIve years rolling returns for Stericycle.

Annualized Returns

Which funds bought or sold SRCL recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-05-22
AMERIPRISE FINANCIAL INC
reduced
-22.37
-4,800,740
10,133,300
-%
2023-05-18
SkyView Investment Advisors, LLC
added
17.33
11,000
453,000
0.11%
2023-05-18
JPMORGAN CHASE & CO
added
42.19
23,933,000
122,466,000
0.01%
2023-05-18
NEW YORK STATE COMMON RETIREMENT FUND
added
1.49
-559,000
4,399,000
0.01%
2023-05-17
Westside Investment Management, Inc.
unchanged
-
4,357
4,361
-%
2023-05-17
Advisory Services Network, LLC
reduced
-7.16
-60,002
258,346
0.01%
2023-05-17
KB FINANCIAL PARTNERS, LLC
added
16.03
5,000
413,000
0.12%
2023-05-17
Thrivent Financial for Lutherans
reduced
-0.92
-164,000
1,061,000
-%
2023-05-16
CASTLEARK MANAGEMENT LLC
reduced
-99.37
-6,050,510
33,580
-%
2023-05-16
SUSQUEHANNA INTERNATIONAL GROUP, LLP
reduced
-12.83
-64,784
207,366
-%

1–10 of 48

Latest Funds Activity

Are funds buying SRCL calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own SRCL
No. of Funds

Stericycle News

MarketBeat
Bank of Nova Scotia Sells 9154 Shares of Stericycle, Inc. (NASDAQ ....
MarketBeat,
29 minutes ago
Scene for Dummies: Everything Hollywood Undead
Nuclear Waste Treatment Market Recent Trends and Growth 2023 ....
Scene for Dummies: Everything Hollywood Undead,
25 hours ago
Herald & Review
Zacks Investment Research
Investing.com Australia

Schedule 13G FIlings of Stericycle

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
price t rowe associates inc /md/
4.9%
4,542,380
SC 13G/A
Feb 14, 2023
clarkston capital partners, llc
6.87%
6,332,330
SC 13G
Feb 14, 2023
alliancebernstein l.p.
7.6%
6,963,391
SC 13G/A
Feb 09, 2023
vanguard group inc
9.60%
8,845,201
SC 13G/A
Feb 08, 2023
black creek investment management inc.
5.59%
0
SC 13G
Feb 03, 2023
blackrock inc.
8.5%
7,803,191
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
12.0%
11,062,819
SC 13G/A
Feb 14, 2022
alliancebernstein l.p.
7.4%
6,841,439
SC 13G/A
Feb 10, 2022
vanguard group inc
9.10%
8,358,752
SC 13G/A
Feb 03, 2022
baillie gifford & co
4.72%
4,337,921
SC 13G/A

SRCL Fair Value

Stericycle fair value in different scenarios

The table shows the Fair Value estimates for Stericycle for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

18.60

-57.09%

24.16

-44.27%

29.38

-32.23%

34.40

-20.65%

40.84

-5.79%
Current Inflation

18.06

-58.34%

23.15

-46.60%

27.92

-35.59%

32.49

-25.05%

38.28

-11.70%
Very High Inflation

17.34

-60.00%

21.83

-49.64%

26.06

-39.88%

30.07

-30.63%

35.06

-19.12%

Historical Stericycle Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Stericycle

View All Filings
Date Filed Form Type Document
May 18, 2023
8-K
Current Report
May 17, 2023
3
Insider Trading
May 17, 2023
4
Insider Trading
May 17, 2023
4
Insider Trading
May 17, 2023
4
Insider Trading
May 17, 2023
4
Insider Trading
May 17, 2023
4
Insider Trading
May 17, 2023
4
Insider Trading
May 17, 2023
4
Insider Trading
May 17, 2023
4
Insider Trading

Latest Insider Trading transactions for SRCL

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-05-01
Rogers Kurt
sold (taxes)
-192,813
45.55
-4,233
evp & general counsel
2023-05-01
Rogers Kurt
acquired
-
-
11,068
evp & general counsel
2023-04-14
Weisman Michael
acquired
-
-
333
evp corp ethics and compliance
2023-04-14
Weisman Michael
sold (taxes)
-4,116
42.00
-98.00
evp corp ethics and compliance
2023-04-01
Rogers Kurt
sold (taxes)
-109,374
43.61
-2,508
evp & general counsel
2023-04-01
Rogers Kurt
acquired
-
-
8,559
evp & general counsel
2023-03-15
Rogers Kurt
sold (taxes)
-33,314
42.82
-778
evp & general counsel
2023-03-15
White Stephen Cory
acquired
-
-
2,409
evp & chief commercial officer
2023-03-15
Weisman Michael
sold (taxes)
-19,397
42.82
-453
evp corp ethics and compliance
2023-03-15
Culotta Dominic
sold (taxes)
-22,609
42.82
-528
evp engineering

1–10 of 50

Cindy J. Miller
15000
Stericycle, Inc., together with its subsidiaries, provides regulated and compliance solutions in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including sharps disposable and management solutions; pharmaceutical waste services; hazardous waste disposal; maritime waste services, such as seaport and airport waste; and compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed, and EnviroAssure brand names. It also provides secure information destruction services, including document and hard drive destruction services under the Shred-it brand; and communication solutions, such as appointment reminders, secure messaging, event registration, and other communications specifically for hospitals and integrated delivery networks. The company serves healthcare businesses, including hospitals, physician and dental practices, outpatient clinics, long-term care facilities, etc.; retailers and manufacturers; financial and professional service providers; governmental entities; and other businesses. Stericycle, Inc. was incorporated in 1989 and is headquartered in Bannockburn, Illinois.

SRCL Income Statement

2023-03-31
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]  
Revenues$ 684.3$ 664.2
Cost of revenues423.3419.7
Gross profit261.0244.5
Selling, general and administrative expenses216.0238.6
Divestiture losses, net5.00.0
Income from operations40.05.9
Interest expense, net(20.4)(16.3)
Other income (expense), net0.2(0.8)
Income (Loss) before income taxes19.8(11.2)
Income tax expense(8.5)(2.9)
Net income (loss)11.3(14.1)
Net income attributable to noncontrolling interests(0.1)(0.1)
Net income (loss) attributable to Stericycle, Inc. common shareholders$ 11.2$ (14.2)
Income (Loss) per common share attributable to Stericycle, Inc. common shareholders:  
Basic (in dollars per share)$ 0.12$ (0.15)
Diluted (in dollars per share)$ 0.12$ (0.15)
Weighted average number of common shares outstanding:  
Basic (in shares)92.392.0
Diluted (in shares)92.792.0

SRCL Balance Sheet

2023-03-31
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Current Assets:  
Cash and cash equivalents$ 60.0$ 56.0
Accounts receivable, less allowance for doubtful accounts of $50.2 in 2023 and $53.3 in 2022419.5414.5
Prepaid expenses34.733.2
Other current assets49.555.0
Total Current Assets563.7558.7
Property, plant and equipment, less accumulated depreciation of $677.1 in 2023 and $657.7 in 2022713.0715.7
Operating lease right-of-use assets414.7398.9
Goodwill2,787.82,784.9
Intangible assets, less accumulated amortization of $853.1 in 2023 and $823.3 in 2022784.8811.1
Other assets68.064.8
Total Assets5,332.05,334.1
Current Liabilities:  
Current portion of long-term debt16.222.3
Bank overdrafts2.42.9
Accounts payable195.3213.5
Accrued liabilities220.7244.1
Operating lease liabilities95.491.2
Other current liabilities50.547.9
Total Current Liabilities580.5621.9
Long-term debt, net1,486.51,484.0
Long-term operating lease liabilities340.2329.0
Deferred income taxes431.8427.0
Long-term income taxes payable11.411.8
Other liabilities35.635.9
Total Liabilities2,886.02,909.6
Commitments and contingencies
EQUITY  
Common stock (par value $0.01 per share, 120.0 shares authorized, 92.4 and 92.2 issued and outstanding in 2023 and 2022, respectively)0.90.9
Additional paid-in capital1,289.21,285.4
Retained earnings1,422.01,410.8
Accumulated other comprehensive loss(266.7)(276.9)
Total Stericycle, Inc.’s Equity2,445.42,420.2
Noncontrolling interests0.64.3
Total Equity2,446.02,424.5
Total Liabilities and Equity$ 5,332.0$ 5,334.1